Business Context and Reporting Period
Akebia Therapeutics, Inc. (AKBA) filed a Form 8-K on May 26, 2023, reporting a material event under Regulation FD. The filing details the assignment of an office lease located at One Marina Park Drive, Cambridge, Massachusetts.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. The only specific financial figure disclosed is a one-time payment of $1,349,731.00 made by the Company to LG Chem Life Sciences Innovation Center, Inc. as part of the lease assignment.
Material Changes
On May 26, 2023, the Company assigned all rights, title, and interest in its existing office lease to LG Chem. Consequently, the Company has no further obligations for rent or other payments under this specific lease agreement.
Outlook, Risks, and Management Commentary
The filing contains no forward-looking guidance, management commentary on future operations, or discussion of risks beyond the immediate transaction. The transaction effectively terminates the Company's liability for the specified lease.
Key Facts for Investor Verification
- Transaction Date: May 26, 2023.
- Counterparty: LG Chem Life Sciences Innovation Center, Inc.
- Payment Made: $1,349,731.00 paid to LG Chem to facilitate the assignment.
- Liability Status: The Company has no further rent obligations under the One Marina Park Drive lease.
- Financial Impact: The filing does not specify the impact on the Company's overall cash position or operating expenses beyond the specific payment noted.